Form 4: GoodRx Holdings Chairman Trevor Bezdek Reports Stock Transactions
SEC Form 4
Trevor Bezdek, Chairman of GoodRx Holdings, reports the vesting and conversion of restricted stock units and Class B common stock into Class A common stock.
Summary
- On June 1, 2024, Trevor Bezdek, Chairman of GoodRx Holdings, engaged in several transactions involving the company's stock.
- These transactions included the vesting of 256,594 restricted stock units, each representing a contingent right to receive one share of Class B common stock.
- Bezdek also converted 256,594 shares of Class B common stock into Class A common stock.
- Additionally, 130,042 shares of Class B common stock were used to cover tax obligations at a price of $7.87 per share.
- Finally, 126,552 shares of Class B common stock were converted into Class A common stock.
- Following these transactions, Bezdek directly owns 5,265,442 shares of Class A Common Stock and 256,594 Restricted Stock Units.
Sentiment
Score: 5
Explanation: This is a neutral filing, simply reporting stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common in the pharmaceutical and healthcare technology industry. These transactions are a normal part of executive compensation and do not necessarily indicate a change in the company's prospects.
Comparison to Industry Standards
- Executive stock transactions are a common occurrence in publicly traded companies, particularly in the tech and healthcare sectors.
- Companies like Teladoc Health, CVS Health, and Walgreens Boots Alliance also see regular Form 4 filings from their executives.
- The vesting and conversion of restricted stock units are standard compensation practices to align executive interests with shareholder value.
- The amounts and values involved are typical for a chairman-level executive in a company of GoodRx's size and market capitalization.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Shareholders may see a slight dilution as Class B shares convert to Class A shares, but this is a standard part of the company's capital structure.
- Employees are not directly affected by these transactions.
Key Dates
| Date | Description |
|---|---|
| September 1, 2020 | Commencement date of the 16 equal quarterly installments for the vesting of restricted stock units. |
| September 25, 2027 | Date upon which each share of Class B common stock is convertible into one share of the Issuer's Class A common stock. |
| 06/01/2024 | Date of the reported transactions including vesting of restricted stock units and conversion of Class B common stock. |
| 06/03/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.